VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,691 | -55.7% | 1,354,400 | +15.9% | 0.02% | -46.3% |
| Q2 2023 | $28,653 | +6.1% | 1,168,100 | +0.7% | 0.04% | +13.9% |
| Q1 2023 | $27,005 | +0.8% | 1,160,500 | +9.6% | 0.04% | -2.7% |
| Q4 2022 | $26,788 | -99.9% | 1,058,400 | -30.0% | 0.04% | -9.8% |
| Q3 2022 | $29,161,000 | +103.6% | 1,512,494 | +168.9% | 0.04% | +141.2% |
| Q2 2022 | $14,324,000 | +490.0% | 562,400 | +495.8% | 0.02% | +466.7% |
| Q1 2022 | $2,428,000 | +0.2% | 94,400 | +63.0% | 0.00% | 0.0% |
| Q4 2021 | $2,424,000 | -36.0% | 57,900 | -27.7% | 0.00% | -40.0% |
| Q2 2021 | $3,787,000 | +88.9% | 80,102 | +36.9% | 0.01% | +150.0% |
| Q1 2020 | $2,005,000 | – | 58,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |